Suh, S.H.; Choi, H.S.; Kim, C.S.; Kim, I.J.; Ma, S.K.; Scholey, J.W.; Kim, S.W.; Bae, E.H.
Olmesartan Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome by Suppressing Tubular Expression of TGFβ. Int. J. Mol. Sci. 2019, 20, 3843.
https://doi.org/10.3390/ijms20153843
AMA Style
Suh SH, Choi HS, Kim CS, Kim IJ, Ma SK, Scholey JW, Kim SW, Bae EH.
Olmesartan Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome by Suppressing Tubular Expression of TGFβ. International Journal of Molecular Sciences. 2019; 20(15):3843.
https://doi.org/10.3390/ijms20153843
Chicago/Turabian Style
Suh, Sang Heon, Hong Sang Choi, Chang Seong Kim, In Jin Kim, Seong Kwon Ma, James W. Scholey, Soo Wan Kim, and Eun Hui Bae.
2019. "Olmesartan Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome by Suppressing Tubular Expression of TGFβ" International Journal of Molecular Sciences 20, no. 15: 3843.
https://doi.org/10.3390/ijms20153843
APA Style
Suh, S. H., Choi, H. S., Kim, C. S., Kim, I. J., Ma, S. K., Scholey, J. W., Kim, S. W., & Bae, E. H.
(2019). Olmesartan Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome by Suppressing Tubular Expression of TGFβ. International Journal of Molecular Sciences, 20(15), 3843.
https://doi.org/10.3390/ijms20153843